S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
Log in

NYSEAMERICAN:OCXOncoCyte News Headlines

$2.37
+0.19 (+8.72 %)
(As of 04/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.22
Now: $2.37
$2.39
50-Day Range N/A
52-Week Range
$1.50
Now: $2.37
$5.60
Volume91,600 shs
Average Volume265,303 shs
Market Capitalization$148.06 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

OncoCyte (NYSEAMERICAN OCX) News Headlines

Source:
DateHeadline
Ronald Asbury Andrews Acquires 27,216 Shares of OncoCyte Corp (NYSEAMERICAN:OCX) StockRonald Asbury Andrews Acquires 27,216 Shares of OncoCyte Corp (NYSEAMERICAN:OCX) Stock
www.americanbankingnews.com - April 1 at 4:56 PM
Monday Sector Leaders: Shipping, Diagnostics - NasdaqMonday Sector Leaders: Shipping, Diagnostics - Nasdaq
www.nasdaq.com - March 31 at 4:52 AM
OncoCyte (NYSEAMERICAN:OCX) Announces Quarterly  Earnings ResultsOncoCyte (NYSEAMERICAN:OCX) Announces Quarterly Earnings Results
www.americanbankingnews.com - March 26 at 11:29 AM
Edited Transcript of OCX earnings conference call or presentation 25-Mar-20 8:30pm GMT - Yahoo FinanceEdited Transcript of OCX earnings conference call or presentation 25-Mar-20 8:30pm GMT - Yahoo Finance
finance.yahoo.com - March 26 at 7:23 AM
Edited Transcript of OCX earnings conference call or presentation 25-Mar-20 8:30pm GMTEdited Transcript of OCX earnings conference call or presentation 25-Mar-20 8:30pm GMT
finance.yahoo.com - March 26 at 7:23 AM
Chardan Capital Reiterates Buy Rating for OncoCyte (NYSEAMERICAN:OCX)Chardan Capital Reiterates Buy Rating for OncoCyte (NYSEAMERICAN:OCX)
www.americanbankingnews.com - March 26 at 6:35 AM
OncoCyte Corporation (OCX) CEO Ronald Andrews on Q4 2019 Results - Earnings Call Transcript - Seeking AlphaOncoCyte Corporation (OCX) CEO Ronald Andrews on Q4 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 26 at 1:41 AM
BRIEF-Oncocyte Corp Files For Common Stock Offering Of Up To $25.0 Mln - SEC Filing - ReutersBRIEF-Oncocyte Corp Files For Common Stock Offering Of Up To $25.0 Mln - SEC Filing - Reuters
www.reuters.com - March 20 at 7:11 PM
OncoCyte (OCX) Scheduled to Post Earnings on WednesdayOncoCyte (OCX) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - March 19 at 8:41 AM
Oncocyte Announces the Launch of CLIA-validated DetermaIO™, a Novel Gene Expression-Based Immune Therapy Response Predictor, for Research Use by Biopharmaceutical Companies and Researchers - GlobeNewswireOncocyte Announces the Launch of CLIA-validated DetermaIO™, a Novel Gene Expression-Based Immune Therapy Response Predictor, for Research Use by Biopharmaceutical Companies and Researchers - GlobeNewswire
www.globenewswire.com - March 19 at 8:21 AM
ONCOCYTE TO REPORT FOURTH QUARTER AND FISCAL 2019 FINANCIAL RESULTS ON WEDNESDAY, MARCH 25 - GlobeNewswireONCOCYTE TO REPORT FOURTH QUARTER AND FISCAL 2019 FINANCIAL RESULTS ON WEDNESDAY, MARCH 25 - GlobeNewswire
www.globenewswire.com - March 19 at 8:21 AM
Oncocyte Announces the Launch of CLIA-validated DetermaIO™, a Novel Gene Expression-Based Immune Therapy Response Predictor, for Research Use by Biopharmaceutical Companies and ResearchersOncocyte Announces the Launch of CLIA-validated DetermaIO™, a Novel Gene Expression-Based Immune Therapy Response Predictor, for Research Use by Biopharmaceutical Companies and Researchers
finance.yahoo.com - March 19 at 8:21 AM
ONCOCYTE TO REPORT FOURTH QUARTER AND FISCAL 2019 FINANCIAL RESULTS ON WEDNESDAY, MARCH 25 - Yahoo FinanceONCOCYTE TO REPORT FOURTH QUARTER AND FISCAL 2019 FINANCIAL RESULTS ON WEDNESDAY, MARCH 25 - Yahoo Finance
finance.yahoo.com - March 18 at 11:57 PM
Short Interest in OncoCyte Corp (NYSEAMERICAN:OCX) Expands By 7.5%Short Interest in OncoCyte Corp (NYSEAMERICAN:OCX) Expands By 7.5%
www.americanbankingnews.com - March 15 at 5:06 AM
Oncocyte Closes Merger Agreement to Acquire Insight Genetics - StreetInsider.comOncocyte Closes Merger Agreement to Acquire Insight Genetics - StreetInsider.com
www.streetinsider.com - February 6 at 11:16 PM
Form 8-K OncoCyte Corp For: Jan 31 - StreetInsider.comForm 8-K OncoCyte Corp For: Jan 31 - StreetInsider.com
www.streetinsider.com - February 5 at 1:12 PM
Oncocyte Closes Merger Agreement to Acquire Insight Genetics - GlobeNewswireOncocyte Closes Merger Agreement to Acquire Insight Genetics - GlobeNewswire
www.globenewswire.com - February 5 at 8:12 AM
OncoCyte (OCX) to Acquire Insight Genetics - StreetInsider.comOncoCyte (OCX) to Acquire Insight Genetics - StreetInsider.com
www.streetinsider.com - February 5 at 8:12 AM
Oncocyte Announces Relocation of its Headquarters to Orange County, California - Yahoo FinanceOncocyte Announces Relocation of its Headquarters to Orange County, California - Yahoo Finance
finance.yahoo.com - January 30 at 11:23 AM
OncoCyte Enters Into The Cancer Immunotherapy Field With The Acquisition Of Insight Genetics - Seeking AlphaOncoCyte Enters Into The Cancer Immunotherapy Field With The Acquisition Of Insight Genetics - Seeking Alpha
seekingalpha.com - January 23 at 4:41 AM
Health Care Sector Update for 01/13/2020: ABMD,OCX,IOVA,CLLS,NVS - NasdaqHealth Care Sector Update for 01/13/2020: ABMD,OCX,IOVA,CLLS,NVS - Nasdaq
www.nasdaq.com - January 13 at 10:41 PM
Oncocyte Announces the Commercial Availability of DetermaRx™, the First Test for Chemotherapy Benefit Prediction in Patients with Early Stage Non-Small Cell Lung Cancer - Yahoo FinanceOncocyte Announces the Commercial Availability of DetermaRx™, the First Test for Chemotherapy Benefit Prediction in Patients with Early Stage Non-Small Cell Lung Cancer - Yahoo Finance
finance.yahoo.com - January 13 at 10:41 PM
Oncocyte Announces the Commercial Availability of DetermaRx™, the First Test for Chemotherapy Benefit Prediction in Patients with Early Stage Non-Small Cell Lung Cancer - GlobeNewswireOncocyte Announces the Commercial Availability of DetermaRx™, the First Test for Chemotherapy Benefit Prediction in Patients with Early Stage Non-Small Cell Lung Cancer - GlobeNewswire
www.globenewswire.com - January 13 at 5:41 PM
Oncocyte Announces Definitive Agreement to Acquire Insight Genetics - GlobeNewswireOncocyte Announces Definitive Agreement to Acquire Insight Genetics - GlobeNewswire
www.globenewswire.com - January 11 at 9:34 PM
OncoCyte to acquire Insight Genetics - Seeking AlphaOncoCyte to acquire Insight Genetics - Seeking Alpha
seekingalpha.com - January 10 at 8:55 PM
48 Biggest Movers From Yesterday - Benzinga48 Biggest Movers From Yesterday - Benzinga
www.benzinga.com - January 8 at 3:37 PM
OncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™ - StreetInsider.comOncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™ - StreetInsider.com
www.streetinsider.com - January 8 at 3:37 PM
OncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™ - GlobeNewswireOncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™ - GlobeNewswire
www.globenewswire.com - January 8 at 2:38 AM
OncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™ - Yahoo FinanceOncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™ - Yahoo Finance
finance.yahoo.com - January 7 at 4:37 PM
OncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™OncoCyte Announces Successful Completion of CLIA Validation Study of DetermaDx™
finance.yahoo.com - January 7 at 4:37 PM
OncoCyte (OCX) Announces $7.6M Registered Offering - StreetInsider.comOncoCyte (OCX) Announces $7.6M Registered Offering - StreetInsider.com
www.streetinsider.com - January 4 at 1:26 AM
OncoCyte Announces $7.6 Million Registered Offering NYSE:OCX - GlobeNewswireOncoCyte Announces $7.6 Million Registered Offering NYSE:OCX - GlobeNewswire
www.globenewswire.com - January 2 at 9:50 PM
Lineage Cell Therapeutics Conducts Sale of Shares in OncoCyte Corporation - Business WireLineage Cell Therapeutics Conducts Sale of Shares in OncoCyte Corporation - Business Wire
www.businesswire.com - January 2 at 9:50 PM
Hedge Funds Are Dumping OncoCyte Corporation (OCX) - Yahoo FinanceHedge Funds Are Dumping OncoCyte Corporation (OCX) - Yahoo Finance
finance.yahoo.com - December 23 at 6:55 PM
Hedge Funds Have Never Been More Bullish On SB Financial Group, Inc. (SBFG) - Yahoo FinanceHedge Funds Have Never Been More Bullish On SB Financial Group, Inc. (SBFG) - Yahoo Finance
finance.yahoo.com - November 30 at 1:35 PM
OncoCyte to Participate at Two Upcoming Investor Conferences in New York - Yahoo FinanceOncoCyte to Participate at Two Upcoming Investor Conferences in New York - Yahoo Finance
finance.yahoo.com - November 27 at 1:01 PM
Edited Transcript of OCX earnings conference call or presentation 14-Nov-19 9:30pm GMT - Yahoo FinanceEdited Transcript of OCX earnings conference call or presentation 14-Nov-19 9:30pm GMT - Yahoo Finance
finance.yahoo.com - November 25 at 8:34 PM
OncoCyte Corporation (OCX) CEO Ronald Andrews on Q3 2019 Results - Earnings Call TranscriptOncoCyte Corporation (OCX) CEO Ronald Andrews on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 15 at 12:13 AM
OncoCyte Corporation (OCX) CEO Ronald Andrews on Q3 2019 Results - Earnings Call Transcript - Seeking AlphaOncoCyte Corporation (OCX) CEO Ronald Andrews on Q3 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 15 at 12:06 AM
OncoCyte Provides Corporate Update and Reports Third Quarter 2019 Financial Results - GlobeNewswireOncoCyte Provides Corporate Update and Reports Third Quarter 2019 Financial Results - GlobeNewswire
www.globenewswire.com - November 14 at 7:05 PM
Form 424B5 OncoCyte Corp - StreetInsider.comForm 424B5 OncoCyte Corp - StreetInsider.com
www.streetinsider.com - November 14 at 9:03 AM
Form 8-K OncoCyte Corp For: Nov 13 - StreetInsider.comForm 8-K OncoCyte Corp For: Nov 13 - StreetInsider.com
www.streetinsider.com - November 14 at 9:03 AM
Lineage Cell Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update - Yahoo FinanceLineage Cell Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update - Yahoo Finance
finance.yahoo.com - November 13 at 12:25 AM
OncoCyte to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019 - GlobeNewswireOncoCyte to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019 - GlobeNewswire
www.globenewswire.com - November 11 at 6:04 PM
OncoCyte to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019 - Yahoo FinanceOncoCyte to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019 - Yahoo Finance
finance.yahoo.com - November 11 at 1:03 PM
OncoCyte to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019OncoCyte to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019
finance.yahoo.com - November 11 at 1:03 PM
Oncocyte Announces Strategic Support of GO2 Foundation for Lung Cancer - GlobeNewswireOncocyte Announces Strategic Support of GO2 Foundation for Lung Cancer - GlobeNewswire
www.globenewswire.com - November 8 at 4:19 PM
OncoCyte to Present Data on Physician Decision Making around Lung Nodule Management for the Early Diagnosis of Lung Cancer at the Managed Care Conference AMCP Nexus 2019 - GlobeNewswireOncoCyte to Present Data on Physician Decision Making around Lung Nodule Management for the Early Diagnosis of Lung Cancer at the Managed Care Conference AMCP Nexus 2019 - GlobeNewswire
www.globenewswire.com - November 1 at 7:32 PM
OncoCyte to Present Data on Physician Decision Making around Lung Nodule Management for the Early Diagnosis of Lung Cancer at the Managed Care Conference AMCP Nexus 2019 - Yahoo FinanceOncoCyte to Present Data on Physician Decision Making around Lung Nodule Management for the Early Diagnosis of Lung Cancer at the Managed Care Conference AMCP Nexus 2019 - Yahoo Finance
finance.yahoo.com - October 31 at 1:52 PM
OncoCyte to Present Data on Physician Decision Making around Lung Nodule Management for the Early Diagnosis of Lung Cancer at the Managed Care Conference AMCP Nexus 2019OncoCyte to Present Data on Physician Decision Making around Lung Nodule Management for the Early Diagnosis of Lung Cancer at the Managed Care Conference AMCP Nexus 2019
finance.yahoo.com - October 31 at 8:51 AM
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel